About GoodGut
GoodGut is a company based in Girona (Spain) founded in 2014 was acquired by HIPRA in September 2021. GoodGut has raised $900.24 thousand across 2 funding rounds from investors including HIPRA and Business Angels Girona. GoodGut offers products and services including TestUrGut, RAID-Dx, RAID-Monitor, RAID-CRC, and RAID-Prediction. GoodGut operates in a competitive market with competitors including Pendulum, Prometheus Laboratories, Viome Life Sciences, NinePoint Medical and InDex Pharmaceuticals, among others.
- Headquarter Girona, Spain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GoodGut
GoodGut offers a comprehensive portfolio of products and services, including TestUrGut, RAID-Dx, RAID-Monitor, RAID-CRC, and RAID-Prediction.
Assesses microbiota status to diagnose and improve intestinal health.
Diagnoses irritable bowel syndrome through microbiota evaluation.
Monitors inflammatory bowel diseases for better disease management.
Evaluates risk of colorectal cancer via microbiota analysis.
Predicts digestive disease progression using advanced testing.
Supports digestive health as a supplementary treatment option.
Funding Insights of GoodGut
GoodGut has successfully raised a total of $900.24K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $667.55 thousand completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GoodGut
GoodGut has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include HIPRA and Business Angels Girona.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A non-profit network of angel investors in Girona is operated.
|
Locked | Locked | Locked | |
|
Vaccines and diagnostic kits for animal diseases are developed.
|
Locked | Locked | Locked |
Investor details for GoodGut
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GoodGut
Investment portfolio details for GoodGut
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GoodGut
Detailed financials for GoodGut
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Goodgut Comparisons
Peer comparison for GoodGut
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GoodGut
GoodGut operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pendulum, Prometheus Laboratories, Viome Life Sciences, NinePoint Medical and InDex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pendulum is focused on developing advanced probiotic solutions.
|
|
| Locked | Locked | Locked |
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
|
|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| Locked | Locked | Locked |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| Locked | Locked | Locked |
Live bacterial therapeutics and biomarkers are developed for multiple diseases.
|
Detailed competitors of GoodGut
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Goodgut
Complete news archive for GoodGut
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GoodGut
GoodGut was founded in 2014.
GoodGut is headquartered in Girona, Spain. It is registered at Girona, Cataluna, Spain.
GoodGut is a funded company, having raised a total of $900.24K across 2 funding rounds to date.
GoodGut is focussed on diagnosis and treatment of digestive diseases based on a know -how that conceives the intestinal microbiota as a determinant factor for digestive diseases development. GoodGut is a spin-off initiative of the University of Girona (UdG) and the Biomedical Research Institute of Girona. The main GoodGut objective is to offer technological instruments for a faster, more reliable and cost-effective digestive diseases diagnosis than the existing methods. At the same time, GoodGut wants to provide therapy for improving the life quality of patients with delicated digestive health. They are currently developing RAID-CRC (an automated stool-based assay to detect microbiological markers), a prediagnostic test for colorectal cancer, and PREVIPECT, a prebiotic for irritable bowel syndrome.
GoodGut's top competitors include Pendulum, Viome Life Sciences and Prometheus Laboratories.
GoodGut offers TestUrGut, RAID-Dx, RAID-Monitor, RAID-CRC, and 2 more products and services.
GoodGut has 2 investors. Key investors include HIPRA, and Business Angels Girona.